Why is Brooks Lab. falling/rising?

As of 25-Jul, Brooks Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 152.10, which reflects a decrease of Rs 3.1 or 2.0%. The stock has underperformed its sector by 2.17% today and has shown high volatility with an intraday volatility of 991.4%. Over the past week, the stock has decreased by 2.87%, while it has seen a modest increase of 1.40% over the past month. Despite a strong performance in the last year with a return of 68.44%, the company has faced challenges, including a weak long-term fundamental strength indicated by an average Return on Equity (ROE) of 0% and a declining annual growth rate in net sales of -2.90% over the last five years.
In the broader market context, the Sensex has only declined by 0.36% over the past week, indicating that Brooks Laboratories Ltd's short-term performance is significantly worse than the benchmark. While the company has shown positive results in terms of net sales growth and has outperformed the BSE500 in the long term, the stock's valuation remains high with a Price to Book Value of 4.6, and its ability to service debt is weak. This combination of high valuation, poor long-term growth prospects, and falling investor participation likely contributes to the stock's current downward movement.